Global Antibody Services Market

Antibody Services Comprehensive Study by Type (Polyclonal antibody, Monoclonal antibody, Murine, Chimeric, Humanize, Other), Application (Gastroenterology, Rheumatology, Infection, Cardiology, Hematology/Oncology, Transplantation, Experimental Biology, Medicine, Biomedical Research, Diagnostic Testing and therapy, Others) Players and Region - Global Market Outlook to 2028

Antibody Services Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 13%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Antibody Services Market Scope
When foreign molecules enters into body then in response immune system produces host proteins which are called antibodies Researchers these days creates antibodies for different diseases by injecting viruses in the bodies of animal. . In response to those antibodies are produced which are studied carefully for human usage. Some of the products are Rituxan, Remicade, Avastin, Humira, and Herceptin. Antibody Services is expected to index utmost CAGR in the course of forecasted period.

According to AMA, the Global Antibody Services market is expected to see growth rate of 13.0%

Number of players are present in the market such as Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH; Pall Corp, INTEGRA Biosciences AG, Fiber Cell Systems Inc. and others henceforth market is fragmented. Increasing no of infectious diseases thriving the practice for new research in antibody services hence increasing the competition. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Antibody Services market throughout the predicted period.

ImmunoPrecise (Canada), Thermo Fisher Scientific, Inc. (United States), GE Healthcare (United States), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), Cellab GmbH (Germany), Pall Corp (United States), INTEGRA Biosciences AG (United States), Fiber Cell Systems Inc. (United States), GeneTex, Inc. (United States), Eli Lilly and Company (United States), Roche Diagnostics Corporation (United States), Abbott Laboratories, Genentech (San Francisco), Sigma-Aldrich Corporation (United States), GE Healthcare (United States), Cusabio Technology LLC (United States) and Thermo Fisher Scientific, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Abcam plc (United Kingdom) and Merck Millipore (United States).

Segmentation Overview
The study have segmented the market of Global Antibody Services market by Type (Polyclonal antibody, Monoclonal antibody, Murine, Chimeric, Humanize and Other), by Application (Gastroenterology, Rheumatology, Infection, Cardiology, Hematology/Oncology, Transplantation, Experimental Biology, Medicine, Biomedical Research, Diagnostic Testing and therapy and Others) and Region with country level break-up.

On the basis of geography, the market of Antibody Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
The Growing Adoption of Monoclonal Antibodies and The emergence of Targeted Theory for Antibody Services

Market Growth Drivers:
Increasing Use of Protein Restorative in Infectious Diseases and Investment in Research and Development in Healthcare Sector

Challenges:
Intense competition amongst dealers

Restraints:
Straighten Government Regulation for

Opportunities:
Emphasizing on Custom Antibody Production

Market Leaders and their Expansionary Development Strategies
In March 2023, Immunoprecise Antibodies Ltd. an AI-driven biotherapeutic research and Technology Company partnered with Talem Therapeutics LLC, an independently operating subsidiary of IPA, and Libera Bio S.L., to work on intracellular targets with the help of AI-driven antibody discovery. This helped company to expand its presence in antibody services market
Recently in 2018, ImmunoPrecise Antibody Ltd. logged increased revenue of 368% compared to 2017 and also publicizes “Genetic Immunization Platform”. The Asia Pacific is expected to gain foremost stake to antibody services because of increasing patient base and demand for cost-effective drugs.


Key Target Audience
Pharmaceutical and Biotechnology Companies, Hospitals, Private Clinics, Research Institute, Government Agencies, Research Laboratories, Market Research Firms and Others

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • Polyclonal antibody
  • Monoclonal antibody
  • Murine
  • Chimeric
  • Humanize
  • Other
By Application
  • Gastroenterology
  • Rheumatology
  • Infection
  • Cardiology
  • Hematology/Oncology
  • Transplantation
  • Experimental Biology
  • Medicine
  • Biomedical Research
  • Diagnostic Testing and therapy
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use of Protein Restorative in Infectious Diseases
      • 3.2.2. Investment in Research and Development in Healthcare Sector
    • 3.3. Market Challenges
      • 3.3.1. Intense competition amongst dealers
    • 3.4. Market Trends
      • 3.4.1. The Growing Adoption of Monoclonal Antibodies
      • 3.4.2. The emergence of Targeted Theory for Antibody Services
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antibody Services, by Type, Application and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Antibody Services (Value)
      • 5.2.1. Global Antibody Services by: Type (Value)
        • 5.2.1.1. Polyclonal antibody
        • 5.2.1.2. Monoclonal antibody
        • 5.2.1.3. Murine
        • 5.2.1.4. Chimeric
        • 5.2.1.5. Humanize
        • 5.2.1.6. Other
      • 5.2.2. Global Antibody Services by: Application (Value)
        • 5.2.2.1. Gastroenterology
        • 5.2.2.2. Rheumatology
        • 5.2.2.3. Infection
        • 5.2.2.4. Cardiology
        • 5.2.2.5. Hematology/Oncology
        • 5.2.2.6. Transplantation
        • 5.2.2.7. Experimental Biology
        • 5.2.2.8. Medicine
        • 5.2.2.9. Biomedical Research
        • 5.2.2.10. Diagnostic Testing and therapy
        • 5.2.2.11. Others
      • 5.2.3. Global Antibody Services Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Antibody Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. ImmunoPrecise (Canada)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GE Healthcare (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sartorius AG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck KGaA (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Eppendorf AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cellab GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Pall Corp (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. INTEGRA Biosciences AG (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Fiber Cell Systems Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. GeneTex, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Eli Lilly and Company (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Roche Diagnostics Corporation (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Abbott Laboratories, Genentech (San Francisco)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Sigma-Aldrich Corporation (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. GE Healthcare (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Cusabio Technology LLC (United States)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
      • 6.4.18. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.18.1. Business Overview
        • 6.4.18.2. Products/Services Offerings
        • 6.4.18.3. Financial Analysis
        • 6.4.18.4. SWOT Analysis
  • 7. Global Antibody Services Sale, by Type, Application and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Antibody Services (Value)
      • 7.2.1. Global Antibody Services by: Type (Value)
        • 7.2.1.1. Polyclonal antibody
        • 7.2.1.2. Monoclonal antibody
        • 7.2.1.3. Murine
        • 7.2.1.4. Chimeric
        • 7.2.1.5. Humanize
        • 7.2.1.6. Other
      • 7.2.2. Global Antibody Services by: Application (Value)
        • 7.2.2.1. Gastroenterology
        • 7.2.2.2. Rheumatology
        • 7.2.2.3. Infection
        • 7.2.2.4. Cardiology
        • 7.2.2.5. Hematology/Oncology
        • 7.2.2.6. Transplantation
        • 7.2.2.7. Experimental Biology
        • 7.2.2.8. Medicine
        • 7.2.2.9. Biomedical Research
        • 7.2.2.10. Diagnostic Testing and therapy
        • 7.2.2.11. Others
      • 7.2.3. Global Antibody Services Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antibody Services: by Type(USD Million)
  • Table 2. Antibody Services Polyclonal antibody , by Region USD Million (2017-2022)
  • Table 3. Antibody Services Monoclonal antibody , by Region USD Million (2017-2022)
  • Table 4. Antibody Services Murine , by Region USD Million (2017-2022)
  • Table 5. Antibody Services Chimeric , by Region USD Million (2017-2022)
  • Table 6. Antibody Services Humanize , by Region USD Million (2017-2022)
  • Table 7. Antibody Services Other , by Region USD Million (2017-2022)
  • Table 8. Antibody Services: by Application(USD Million)
  • Table 9. Antibody Services Gastroenterology , by Region USD Million (2017-2022)
  • Table 10. Antibody Services Rheumatology , by Region USD Million (2017-2022)
  • Table 11. Antibody Services Infection , by Region USD Million (2017-2022)
  • Table 12. Antibody Services Cardiology , by Region USD Million (2017-2022)
  • Table 13. Antibody Services Hematology/Oncology , by Region USD Million (2017-2022)
  • Table 14. Antibody Services Transplantation , by Region USD Million (2017-2022)
  • Table 15. Antibody Services Experimental Biology , by Region USD Million (2017-2022)
  • Table 16. Antibody Services Medicine , by Region USD Million (2017-2022)
  • Table 17. Antibody Services Biomedical Research , by Region USD Million (2017-2022)
  • Table 18. Antibody Services Diagnostic Testing and therapy , by Region USD Million (2017-2022)
  • Table 19. Antibody Services Others , by Region USD Million (2017-2022)
  • Table 20. South America Antibody Services, by Country USD Million (2017-2022)
  • Table 21. South America Antibody Services, by Type USD Million (2017-2022)
  • Table 22. South America Antibody Services, by Application USD Million (2017-2022)
  • Table 23. Brazil Antibody Services, by Type USD Million (2017-2022)
  • Table 24. Brazil Antibody Services, by Application USD Million (2017-2022)
  • Table 25. Argentina Antibody Services, by Type USD Million (2017-2022)
  • Table 26. Argentina Antibody Services, by Application USD Million (2017-2022)
  • Table 27. Rest of South America Antibody Services, by Type USD Million (2017-2022)
  • Table 28. Rest of South America Antibody Services, by Application USD Million (2017-2022)
  • Table 29. Asia Pacific Antibody Services, by Country USD Million (2017-2022)
  • Table 30. Asia Pacific Antibody Services, by Type USD Million (2017-2022)
  • Table 31. Asia Pacific Antibody Services, by Application USD Million (2017-2022)
  • Table 32. China Antibody Services, by Type USD Million (2017-2022)
  • Table 33. China Antibody Services, by Application USD Million (2017-2022)
  • Table 34. Japan Antibody Services, by Type USD Million (2017-2022)
  • Table 35. Japan Antibody Services, by Application USD Million (2017-2022)
  • Table 36. India Antibody Services, by Type USD Million (2017-2022)
  • Table 37. India Antibody Services, by Application USD Million (2017-2022)
  • Table 38. South Korea Antibody Services, by Type USD Million (2017-2022)
  • Table 39. South Korea Antibody Services, by Application USD Million (2017-2022)
  • Table 40. Taiwan Antibody Services, by Type USD Million (2017-2022)
  • Table 41. Taiwan Antibody Services, by Application USD Million (2017-2022)
  • Table 42. Australia Antibody Services, by Type USD Million (2017-2022)
  • Table 43. Australia Antibody Services, by Application USD Million (2017-2022)
  • Table 44. Rest of Asia-Pacific Antibody Services, by Type USD Million (2017-2022)
  • Table 45. Rest of Asia-Pacific Antibody Services, by Application USD Million (2017-2022)
  • Table 46. Europe Antibody Services, by Country USD Million (2017-2022)
  • Table 47. Europe Antibody Services, by Type USD Million (2017-2022)
  • Table 48. Europe Antibody Services, by Application USD Million (2017-2022)
  • Table 49. Germany Antibody Services, by Type USD Million (2017-2022)
  • Table 50. Germany Antibody Services, by Application USD Million (2017-2022)
  • Table 51. France Antibody Services, by Type USD Million (2017-2022)
  • Table 52. France Antibody Services, by Application USD Million (2017-2022)
  • Table 53. Italy Antibody Services, by Type USD Million (2017-2022)
  • Table 54. Italy Antibody Services, by Application USD Million (2017-2022)
  • Table 55. United Kingdom Antibody Services, by Type USD Million (2017-2022)
  • Table 56. United Kingdom Antibody Services, by Application USD Million (2017-2022)
  • Table 57. Netherlands Antibody Services, by Type USD Million (2017-2022)
  • Table 58. Netherlands Antibody Services, by Application USD Million (2017-2022)
  • Table 59. Rest of Europe Antibody Services, by Type USD Million (2017-2022)
  • Table 60. Rest of Europe Antibody Services, by Application USD Million (2017-2022)
  • Table 61. MEA Antibody Services, by Country USD Million (2017-2022)
  • Table 62. MEA Antibody Services, by Type USD Million (2017-2022)
  • Table 63. MEA Antibody Services, by Application USD Million (2017-2022)
  • Table 64. Middle East Antibody Services, by Type USD Million (2017-2022)
  • Table 65. Middle East Antibody Services, by Application USD Million (2017-2022)
  • Table 66. Africa Antibody Services, by Type USD Million (2017-2022)
  • Table 67. Africa Antibody Services, by Application USD Million (2017-2022)
  • Table 68. North America Antibody Services, by Country USD Million (2017-2022)
  • Table 69. North America Antibody Services, by Type USD Million (2017-2022)
  • Table 70. North America Antibody Services, by Application USD Million (2017-2022)
  • Table 71. United States Antibody Services, by Type USD Million (2017-2022)
  • Table 72. United States Antibody Services, by Application USD Million (2017-2022)
  • Table 73. Canada Antibody Services, by Type USD Million (2017-2022)
  • Table 74. Canada Antibody Services, by Application USD Million (2017-2022)
  • Table 75. Mexico Antibody Services, by Type USD Million (2017-2022)
  • Table 76. Mexico Antibody Services, by Application USD Million (2017-2022)
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Company Basic Information, Sales Area and Its Competitors
  • Table 84. Company Basic Information, Sales Area and Its Competitors
  • Table 85. Company Basic Information, Sales Area and Its Competitors
  • Table 86. Company Basic Information, Sales Area and Its Competitors
  • Table 87. Company Basic Information, Sales Area and Its Competitors
  • Table 88. Company Basic Information, Sales Area and Its Competitors
  • Table 89. Company Basic Information, Sales Area and Its Competitors
  • Table 90. Company Basic Information, Sales Area and Its Competitors
  • Table 91. Company Basic Information, Sales Area and Its Competitors
  • Table 92. Company Basic Information, Sales Area and Its Competitors
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Antibody Services: by Type(USD Million)
  • Table 96. Antibody Services Polyclonal antibody , by Region USD Million (2023-2028)
  • Table 97. Antibody Services Monoclonal antibody , by Region USD Million (2023-2028)
  • Table 98. Antibody Services Murine , by Region USD Million (2023-2028)
  • Table 99. Antibody Services Chimeric , by Region USD Million (2023-2028)
  • Table 100. Antibody Services Humanize , by Region USD Million (2023-2028)
  • Table 101. Antibody Services Other , by Region USD Million (2023-2028)
  • Table 102. Antibody Services: by Application(USD Million)
  • Table 103. Antibody Services Gastroenterology , by Region USD Million (2023-2028)
  • Table 104. Antibody Services Rheumatology , by Region USD Million (2023-2028)
  • Table 105. Antibody Services Infection , by Region USD Million (2023-2028)
  • Table 106. Antibody Services Cardiology , by Region USD Million (2023-2028)
  • Table 107. Antibody Services Hematology/Oncology , by Region USD Million (2023-2028)
  • Table 108. Antibody Services Transplantation , by Region USD Million (2023-2028)
  • Table 109. Antibody Services Experimental Biology , by Region USD Million (2023-2028)
  • Table 110. Antibody Services Medicine , by Region USD Million (2023-2028)
  • Table 111. Antibody Services Biomedical Research , by Region USD Million (2023-2028)
  • Table 112. Antibody Services Diagnostic Testing and therapy , by Region USD Million (2023-2028)
  • Table 113. Antibody Services Others , by Region USD Million (2023-2028)
  • Table 114. South America Antibody Services, by Country USD Million (2023-2028)
  • Table 115. South America Antibody Services, by Type USD Million (2023-2028)
  • Table 116. South America Antibody Services, by Application USD Million (2023-2028)
  • Table 117. Brazil Antibody Services, by Type USD Million (2023-2028)
  • Table 118. Brazil Antibody Services, by Application USD Million (2023-2028)
  • Table 119. Argentina Antibody Services, by Type USD Million (2023-2028)
  • Table 120. Argentina Antibody Services, by Application USD Million (2023-2028)
  • Table 121. Rest of South America Antibody Services, by Type USD Million (2023-2028)
  • Table 122. Rest of South America Antibody Services, by Application USD Million (2023-2028)
  • Table 123. Asia Pacific Antibody Services, by Country USD Million (2023-2028)
  • Table 124. Asia Pacific Antibody Services, by Type USD Million (2023-2028)
  • Table 125. Asia Pacific Antibody Services, by Application USD Million (2023-2028)
  • Table 126. China Antibody Services, by Type USD Million (2023-2028)
  • Table 127. China Antibody Services, by Application USD Million (2023-2028)
  • Table 128. Japan Antibody Services, by Type USD Million (2023-2028)
  • Table 129. Japan Antibody Services, by Application USD Million (2023-2028)
  • Table 130. India Antibody Services, by Type USD Million (2023-2028)
  • Table 131. India Antibody Services, by Application USD Million (2023-2028)
  • Table 132. South Korea Antibody Services, by Type USD Million (2023-2028)
  • Table 133. South Korea Antibody Services, by Application USD Million (2023-2028)
  • Table 134. Taiwan Antibody Services, by Type USD Million (2023-2028)
  • Table 135. Taiwan Antibody Services, by Application USD Million (2023-2028)
  • Table 136. Australia Antibody Services, by Type USD Million (2023-2028)
  • Table 137. Australia Antibody Services, by Application USD Million (2023-2028)
  • Table 138. Rest of Asia-Pacific Antibody Services, by Type USD Million (2023-2028)
  • Table 139. Rest of Asia-Pacific Antibody Services, by Application USD Million (2023-2028)
  • Table 140. Europe Antibody Services, by Country USD Million (2023-2028)
  • Table 141. Europe Antibody Services, by Type USD Million (2023-2028)
  • Table 142. Europe Antibody Services, by Application USD Million (2023-2028)
  • Table 143. Germany Antibody Services, by Type USD Million (2023-2028)
  • Table 144. Germany Antibody Services, by Application USD Million (2023-2028)
  • Table 145. France Antibody Services, by Type USD Million (2023-2028)
  • Table 146. France Antibody Services, by Application USD Million (2023-2028)
  • Table 147. Italy Antibody Services, by Type USD Million (2023-2028)
  • Table 148. Italy Antibody Services, by Application USD Million (2023-2028)
  • Table 149. United Kingdom Antibody Services, by Type USD Million (2023-2028)
  • Table 150. United Kingdom Antibody Services, by Application USD Million (2023-2028)
  • Table 151. Netherlands Antibody Services, by Type USD Million (2023-2028)
  • Table 152. Netherlands Antibody Services, by Application USD Million (2023-2028)
  • Table 153. Rest of Europe Antibody Services, by Type USD Million (2023-2028)
  • Table 154. Rest of Europe Antibody Services, by Application USD Million (2023-2028)
  • Table 155. MEA Antibody Services, by Country USD Million (2023-2028)
  • Table 156. MEA Antibody Services, by Type USD Million (2023-2028)
  • Table 157. MEA Antibody Services, by Application USD Million (2023-2028)
  • Table 158. Middle East Antibody Services, by Type USD Million (2023-2028)
  • Table 159. Middle East Antibody Services, by Application USD Million (2023-2028)
  • Table 160. Africa Antibody Services, by Type USD Million (2023-2028)
  • Table 161. Africa Antibody Services, by Application USD Million (2023-2028)
  • Table 162. North America Antibody Services, by Country USD Million (2023-2028)
  • Table 163. North America Antibody Services, by Type USD Million (2023-2028)
  • Table 164. North America Antibody Services, by Application USD Million (2023-2028)
  • Table 165. United States Antibody Services, by Type USD Million (2023-2028)
  • Table 166. United States Antibody Services, by Application USD Million (2023-2028)
  • Table 167. Canada Antibody Services, by Type USD Million (2023-2028)
  • Table 168. Canada Antibody Services, by Application USD Million (2023-2028)
  • Table 169. Mexico Antibody Services, by Type USD Million (2023-2028)
  • Table 170. Mexico Antibody Services, by Application USD Million (2023-2028)
  • Table 171. Research Programs/Design for This Report
  • Table 172. Key Data Information from Secondary Sources
  • Table 173. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antibody Services: by Type USD Million (2017-2022)
  • Figure 5. Global Antibody Services: by Application USD Million (2017-2022)
  • Figure 6. South America Antibody Services Share (%), by Country
  • Figure 7. Asia Pacific Antibody Services Share (%), by Country
  • Figure 8. Europe Antibody Services Share (%), by Country
  • Figure 9. MEA Antibody Services Share (%), by Country
  • Figure 10. North America Antibody Services Share (%), by Country
  • Figure 11. Global Antibody Services share by Players 2022 (%)
  • Figure 12. Global Antibody Services share by Players (Top 3) 2022(%)
  • Figure 13. Global Antibody Services share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. ImmunoPrecise (Canada) Revenue, Net Income and Gross profit
  • Figure 16. ImmunoPrecise (Canada) Revenue: by Geography 2022
  • Figure 17. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2022
  • Figure 19. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 20. GE Healthcare (United States) Revenue: by Geography 2022
  • Figure 21. Sartorius AG (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Sartorius AG (Germany) Revenue: by Geography 2022
  • Figure 23. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 25. Eppendorf AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Eppendorf AG (Germany) Revenue: by Geography 2022
  • Figure 27. Cellab GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Cellab GmbH (Germany) Revenue: by Geography 2022
  • Figure 29. Pall Corp (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pall Corp (United States) Revenue: by Geography 2022
  • Figure 31. INTEGRA Biosciences AG (United States) Revenue, Net Income and Gross profit
  • Figure 32. INTEGRA Biosciences AG (United States) Revenue: by Geography 2022
  • Figure 33. Fiber Cell Systems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Fiber Cell Systems Inc. (United States) Revenue: by Geography 2022
  • Figure 35. GeneTex, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. GeneTex, Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 38. Eli Lilly and Company (United States) Revenue: by Geography 2022
  • Figure 39. Roche Diagnostics Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 40. Roche Diagnostics Corporation (United States) Revenue: by Geography 2022
  • Figure 41. Abbott Laboratories, Genentech (San Francisco) Revenue, Net Income and Gross profit
  • Figure 42. Abbott Laboratories, Genentech (San Francisco) Revenue: by Geography 2022
  • Figure 43. Sigma-Aldrich Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 44. Sigma-Aldrich Corporation (United States) Revenue: by Geography 2022
  • Figure 45. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 46. GE Healthcare (United States) Revenue: by Geography 2022
  • Figure 47. Cusabio Technology LLC (United States) Revenue, Net Income and Gross profit
  • Figure 48. Cusabio Technology LLC (United States) Revenue: by Geography 2022
  • Figure 49. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 50. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2022
  • Figure 51. Global Antibody Services: by Type USD Million (2023-2028)
  • Figure 52. Global Antibody Services: by Application USD Million (2023-2028)
  • Figure 53. South America Antibody Services Share (%), by Country
  • Figure 54. Asia Pacific Antibody Services Share (%), by Country
  • Figure 55. Europe Antibody Services Share (%), by Country
  • Figure 56. MEA Antibody Services Share (%), by Country
  • Figure 57. North America Antibody Services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • ImmunoPrecise (Canada)
  • Thermo Fisher Scientific, Inc. (United States)
  • GE Healthcare (United States)
  • Sartorius AG (Germany)
  • Merck KGaA (Germany)
  • Eppendorf AG (Germany)
  • Cellab GmbH (Germany)
  • Pall Corp (United States)
  • INTEGRA Biosciences AG (United States)
  • Fiber Cell Systems Inc. (United States)
  • GeneTex, Inc. (United States)
  • Eli Lilly and Company (United States)
  • Roche Diagnostics Corporation (United States)
  • Abbott Laboratories, Genentech (San Francisco)
  • Sigma-Aldrich Corporation (United States)
  • GE Healthcare (United States)
  • Cusabio Technology LLC (United States)
  • Thermo Fisher Scientific, Inc. (United States)
Additional players considered in the study are as follows:
Abcam plc (United Kingdom) , Merck Millipore (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 224 Pages 90 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antibody Services Market Quantitative research analysis
Global Antibody Services Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Antibody Services study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Antibody Services Market is gaining popularity and expected to see strong valuation by 2028 .
According to AMA, the Global Antibody Services market is expected to see growth rate of xx%.
The Antibody Services market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Antibody Services Market Report?

Have a Query? Click Here

Other Related Reports

Liver Disease Treatment Comprehensive Study by Application (Hospital, Clinic, Others), Disease Type (Hepatitis, Autoimmune diseases, Liver tumor, Chronic liver disease, Fatty liver disease.), Treatme...
$ 3650
Cancer Pain Therapeutics Comprehensive Study by Type (Opioids, Non-Steroidal Anti-Inflammatory Drugs, Others), Application (Related Immunotherapy, Radiotherapy, Chemotherapy, Hormone Therapy), End Us...
$ 3350
Antinuclear Antibody Test Comprehensive Study by Type (Reagents and Assay Kits, Software and Services, Systems), Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Scler...
$ 3750
Cell Culture Comprehensive Study by Type (Equipment, Consumables), Application (Biopharmaceutical, Cancer Research, Drug Screening & Development, Tissue Engineering & Regenerative Medicine, Others), ...
$ 3750
Coagulation Factors Comprehensive Study by Type (Coagulation Factor VIIa, Coagulation Factor IX, Coagulation Factor IX, Coagulation Factor IX, Coagulation Factor X, Others), Application (Pharmacy, Ho...
$ 3450
Engineered T Cells Comprehensive Study by Type (Tumor Infiltrating Lymphocytes, T Cell Receptor (TCR), Chimeric Antigen Receptor (CAR)), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Me...
$ 3450